Related references
Note: Only part of the references are listed.Predictors of longitudinal cognitive ageing from age 70 to 82 including APOE e4 status, early-life and lifestyle factors: the Lothian Birth Cohort 1936
Janie Corley et al.
MOLECULAR PSYCHIATRY (2023)
Tamsulosin facilitates depressive-like behaviors in mice: Involvement of endogenous glucocorticoids
Victor A. D. Holanda et al.
BRAIN RESEARCH BULLETIN (2022)
Specific nutrition and metabolic characteristics of critically ill patients with persistent COVID-19
Marina V. Viana et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2022)
A pilot to assess target engagement of terazosin in Parkinson's disease
Jordan L. Schultz et al.
PARKINSONISM & RELATED DISORDERS (2022)
Crystal structure of the α1B-adrenergic receptor reveals molecular determinants of selective ligand recognition
Mattia Deluigi et al.
NATURE COMMUNICATIONS (2022)
Divergent Adaptations in Autonomic Nerve Activity and Neuroimmune Signaling Associated With the Severity of Inflammation in Chronic Colitis
Rhian Stavely et al.
INFLAMMATORY BOWEL DISEASES (2022)
Efficacy and acceptability of psychotherapeutic and pharmacological interventions for trauma-related nightmares: A systematic review and network meta-analysis
Ye Zhang et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
Association between benign prostatic hyperplasia and suicide in South Korea: A nationwide retrospective cohort study
Sang-Uk Lee et al.
PLOS ONE (2022)
α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes
Garrett A. Enten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Stimulation of Alpha-1-Adrenergic Receptor Ameliorates Obesity-Induced Cataracts by Activating Glycolysis and Inhibiting Cataract-Inducing Factors
Yong-Jik Lee et al.
ENDOCRINOLOGY AND METABOLISM (2022)
Genome-wide association studies of COVID-19: Connecting the dots
Leonardo C. Ferreira et al.
INFECTION GENETICS AND EVOLUTION (2022)
Prazosin Treatment Protects Brain and Heart by Diminishing Oxidative Stress and Apoptotic Pathways After Renal Ischemia Reperfusion
Zahra Malekinejad et al.
DRUG RESEARCH (2022)
Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
Salva R. Yurista et al.
CURRENT HEART FAILURE REPORTS (2022)
Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation
Charlotte Szewczykowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Role of Bioenergetics in Neurodegeneration
Taylor A. Strope et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
Laura Latvala et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)
Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation
Yang Wang et al.
FRONTIERS IN CHEMISTRY (2022)
Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis
Helena Chaytow et al.
EBIOMEDICINE (2022)
Glycolysis: The Next Big Breakthrough in Parkinson's Disease
Unaiza Naeem et al.
NEUROTOXICITY RESEARCH (2022)
Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing
Felix Mansbart et al.
BMC GERIATRICS (2022)
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
Akihiko Nishimura et al.
FRONTIERS IN PHARMACOLOGY (2022)
Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases
Ya-Hui Wang et al.
FRONTIERS IN MEDICINE (2022)
Epidemiology and Risk Factors for Dementia
Christina S. Dintica et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2022)
The Selective α1 Antagonist Tamsulosin Alters ECM Distributions and Cellular Metabolic Functions of ARPE 19 Cells in a Concentration-Dependent Manner
Yosuke Ida et al.
BIOENGINEERING-BASEL (2022)
Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19
Man Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
α1-Adrenergic receptors increase glucose oxidation under normal and ischemic conditions in adult mouse cardiomyocytes
Robert S. Papay et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2021)
Cardiac Failure Associated with Medical Therapy of Benign Prostatic Hyperplasia: A Population Based Study
Avril Lusty et al.
JOURNAL OF UROLOGY (2021)
Association of Glycolysis-Enhancing alpha-1 Blockers With Risk of Developing Parkinson Disease
Jacob E. Simmering et al.
JAMA NEUROLOGY (2021)
Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark
Reimar W. Thomsen et al.
JAMA NETWORK OPEN (2021)
The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19
Liam Rose et al.
FRONTIERS IN MEDICINE (2021)
MH-76, a Novel Non-Quinazoline α1-Adrenoceptor Antagonist, but Not Prazosin Reduces Inflammation and Improves Insulin Signaling in Adipose Tissue of Fructose-Fed Rats
Monika Kubacka et al.
PHARMACEUTICALS (2021)
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection
Allison Koenecke et al.
ELIFE (2021)
Association of Clinical and Immunological Characteristics With Disease Severity and Outcomes in 211 Patients With COVID-19 in Wuhan, China
Man Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Current Developments on the Role of α1-Adrenergic Receptors in Cognition, Cardioprotection, and Metabolism
Dianne M. Perez
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS
Jose Angel Lorente et al.
CRITICAL CARE (2021)
Parkinson disease among patients treated for benign prostatic hyperplasia with α1 adrenergic receptor antagonists
Rahul Sasane et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
Gerd Wallukat et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)
Management and outcomes of the small pupil in cataract surgery: iris hooks, Malyugin ring or phenylephrine?
Shafi Balal et al.
EYE (2021)
The alpha(1)-adrenergic receptors in the amygdala regulate the induction of learned despair through protein kinase C-beta signaling
Shisui Fujita et al.
BEHAVIOURAL PHARMACOLOGY (2021)
COVID-19 and Multiorgan Response
Sevim Zaim et al.
CURRENT PROBLEMS IN CARDIOLOGY (2020)
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
Maximilian F. Konig et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
α1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition
Dianne M. Perez
FRONTIERS IN PHARMACOLOGY (2020)
Catecholamine physiology and its implications in patients with COVID-19
Sriram Gubbi et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
An Essential Protective Role for Cardiomyocyte Alpha1a-adrenergic Receptors in a Mouse Model of Myocardial Infarction
Jiandong Zhang et al.
CIRCULATION RESEARCH (2020)
Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms
Yeon Joo Kim et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2020)
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist
Monika Kubacka et al.
HYPERTENSION RESEARCH (2019)
α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database
Bum Sik Tae et al.
JOURNAL OF UROLOGY (2019)
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
Ernesto Manzo et al.
ELIFE (2019)
Metabolic and Nutritional Characteristics of Long-Stay Critically Ill Patients
Marina V. Viana et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases
Rong Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
A plea to stop using the case-control design in retrospective database studies
Martijn J. Schuemie et al.
STATISTICS IN MEDICINE (2019)
Reversal of right ventricular failure by chronic α1A-subtype adrenergic agonist therapy
Patrick M. Cowley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation
Tong Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations
Gretchen L. Sacha et al.
PHARMACOTHERAPY (2019)
Discovery of Pathologic GPCR Aggregation
Ursula Quitterer et al.
FRONTIERS IN MEDICINE (2019)
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist
Gianni Sagratini et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Management of Refractory Vasodilatory Shock
Jacob C. Jentzer et al.
CHEST (2018)
Human Myocardium Has a Robust α1A-Subtype Adrenergic Receptor Inotropic Response
Paul M. L. Janssen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans
M. A. Raskind et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia
Yinghui Duan et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Vasopressors in Sepsis
Kristin P. Colling et al.
SURGICAL INFECTIONS (2018)
Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome
Verena Staedtke et al.
NATURE (2018)
The role of α1-adrenergic receptors in regulating metabolism: increased glucose tolerance, leptin secretion and lipid oxidation
Ting Shi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2017)
α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells
Lauren J. Albee et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Oxymetazoline hydrochloride cream for facial erythema associated with rosacea
Nupur U. Patel et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice
Megan D. Montgomery et al.
PLOS ONE (2017)
Factors influencing biased agonism in recombinant cells expressing the human α1A-adrenoceptor
Edilson Dantas da Silva Junior et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
α1A-Adrenergic receptor prevents cardiac ischemic damage through PKCδ/GLUT1/4-mediated glucose uptake
Ting Shi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2016)
AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis
Nirma D. Perera et al.
NEUROCHEMICAL RESEARCH (2016)
G Protein-Coupled Receptor Heteromers
Ivone Gomes et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo
Monte S. Willis et al.
METABOLOMICS (2016)
1-Adrenoceptors in the hippocampal dentate gyrus involved in learning-dependent long-term potentiation during active-avoidance learning in rats
Jing Lv et al.
NEUROREPORT (2016)
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers
Mallory Batty et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The α1A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium
Patrick M. Cowley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Overexpression of Cardiomyocyte a α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling
Xin Zhao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system
Mark A. Barnes et al.
CYTOKINE (2015)
Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes
Angela Scanzano et al.
INFLAMMATION RESEARCH (2015)
Role for astroglial α1-adrenoreceptors in gliotransmission and control of synaptic plasticity in the neocortex
Yuriy Pankratov et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Adrenergic regulation of innate immunity: a review
Angela Scanzano et al.
FRONTIERS IN PHARMACOLOGY (2015)
Terazosin activates Pgk1 and Hsp90 to promote stress resistance
Xinping Chen et al.
NATURE CHEMICAL BIOLOGY (2015)
Long-term α1B-adrenergic receptor activation shortens lifespan, while α1A-adrenergic receptor stimulation prolongs lifespan in association with decreased cancer incidence
Katie M. Collette et al.
AGE (2014)
Functional roles of CREB as a positive regulator in the formation and enhancement of memory
Satoshi Kida et al.
BRAIN RESEARCH BULLETIN (2014)
Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation
Waleed G. T. Masoud et al.
CARDIOVASCULAR RESEARCH (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The Influence of Depression, Anxiety and Somatization on the Clinical Symptoms and Treatment Response in Patients with Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
Yong June Yang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Prospective Masked Comparison of Intraoperative Floppy Iris Syndrome Severity with Tamsulosin versus Alfuzosin
David F. Chang et al.
OPHTHALMOLOGY (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
A Trial of Prazosin for Combat Trauma PTSD With Nightmares in Active-Duty Soldiers Returned From Iraq and Afghanistan
Murray A. Raskind et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation
M. Perez-Aso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates
Anjana Haridas et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2013)
Selective modulation of lymphoproliferation and cytokine production via intracellular signaling targets by α1- and α2-adrenoceptors and estrogen in splenocytes
Hannah P. Priyanka et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Novel proteins associated with human dilated cardiomyopathy: selective reduction in α1A-adrenergic receptors and increased desensitization proteins
Ting Shi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2013)
Differences in the Signaling Pathways of α1A- and α1B-Adrenoceptors Are Related to Different Endosomal Targeting
Vanessa Segura et al.
PLOS ONE (2013)
Differential Phosphorylation, Desensitization, and Internalization of α1A-Adrenoceptors Activated by Norepinephrine and Oxymetazoline
Juliana Akinaga et al.
MOLECULAR PHARMACOLOGY (2013)
Tamsulosin Potently and Selectively Antagonizes Human Recombinant α1A/1D-Adrenoceptors: Slow Dissociation from the α1A-Adrenoceptor May Account for Selectivity for α1A-Adrenoceptor over α1B-Adrenoceptor Subtype
Shuichi Sato et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury
John R. Ussher et al.
CARDIOVASCULAR RESEARCH (2012)
Identification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer
Sanam Mustafa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Eric R. Kandel
MOLECULAR BRAIN (2012)
α1-adrenergic drugs modulate differentiation and cell death of human erythroleukemia cells through non adrenergic mechanism
Robert Fuchs et al.
EXPERIMENTAL CELL RESEARCH (2011)
Cardiac and neuroprotection regulated by α1-adrenergic receptor subtypes
Dianne M. Perez et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2011)
Long-Term α1A-Adrenergic Receptor Stimulation Improves Synaptic Plasticity, Cognitive Function, Mood, and Longevity
Van A. Doze et al.
MOLECULAR PHARMACOLOGY (2011)
Risk Factors for Intraoperative Floppy Iris Syndrome: A Meta-Analysis
Irini P. Chatziralli et al.
OPHTHALMOLOGY (2011)
Scaling of Brain Metabolism with a Fixed Energy Budget per Neuron: Implications for Neuronal Activity, Plasticity and Evolution
Suzana Herculano-Houzel
PLOS ONE (2011)
Cardiovascular Disease Risk Factors and Cognition in the Elderly
Elizabeth C. Leritz et al.
CURRENT CARDIOVASCULAR RISK REPORTS (2011)
The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT Study
Claus G. Roehrborn et al.
EUROPEAN UROLOGY (2010)
α1A- and α1B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse
Van A. Doze et al.
BRAIN RESEARCH (2009)
α1A/B-Knockout mice explain the native α1D-adrenoceptor's role in vasoconstriction and show that its location is independent of the other α1-subtypes
L. Methven et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
α1-Adrenergic Receptor Subtypes in Nonfailing and Failing Human Myocardium
Brian C. Jensen et al.
CIRCULATION-HEART FAILURE (2009)
Silodosin: A Selective α1A-Adrenergic Receptor Antagonist for the Treatment of Benign Prostatic Hyperplasia
Sara Schilit et al.
CLINICAL THERAPEUTICS (2009)
Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery
Chaim M. Bell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
α1-Adrenergic Receptors Regulate Neurogenesis and Gliogenesis
Manveen K. Gupta et al.
MOLECULAR PHARMACOLOGY (2009)
Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific
Brian C. Jensen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2009)
Location and density of α- and β-adrenoreceptor sub-types in myocardium after mechanical left ventricular unloading
Pippa M. Schnee et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
A Randomized, Controlled Trial of Nasal Phenylephrine in Infants Hospitalized for Bronchiolitis
Shawn Ralston et al.
JOURNAL OF PEDIATRICS (2008)
Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function
Jing-Yin Bao et al.
NEUROIMMUNOMODULATION (2008)
α1-adrenoceptors are required for normal male sexual function
A. Sanbe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder
Murray A. Raskind et al.
BIOLOGICAL PSYCHIATRY (2007)
Contribution of both Ca2+ entry and Ca2+ sensitization to the α1-adrenergic vasoconstriction of rat penile small arteries
Nuria Villalba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Intraoperative floppy-iris syndrome with doxazosin
Marjorie K. Herd
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2007)
Dominance of the alpha(1B)-adrenergic receptor and its subcellular localization in human and TRAMP prostate cancer cell lines
Ting Shi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2007)
Lower urinary tract symptoms and depressive symptoms in elderly men
Samuel Y. S. Wong et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
Absence of malonyl coenzyme a decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury
Jason R. B. Dyck et al.
CIRCULATION (2006)
Transgenic α1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival
Xiao-Jun Du et al.
CARDIOVASCULAR RESEARCH (2006)
Localization of the mouse α1A-adrenergic receptor (AR) in the brain:: α1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors
Robert Papay et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Selective inhibition of α1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop
C Hague et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intraoperative floppy iris syndrome associated with tamsulosin
DF Chang et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2005)
Two α1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation
C Hosoda et al.
MOLECULAR PHARMACOLOGY (2005)
α1A- but not α1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism
BR Rorabaugh et al.
CARDIOVASCULAR RESEARCH (2005)
Evidence for the presence of alpha(1) adrenoceptor subtypes in the human ureter
S Sigala et al.
NEUROUROLOGY AND URODYNAMICS (2005)
Is the failing heart energy starved? On using chemical energy to support cardiac function
JS Ingwall et al.
CIRCULATION RESEARCH (2004)
Characteristics of behavioral abnormalities in α1d-adrenoceptors deficient mice
K Mishima et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of GABAergic transmission in the basolateral amygdala
MFM Braga et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Differential regulation of the cell cycle by α1-adrenergic receptor subtypes
PJ Gonzalez-Cabrera et al.
ENDOCRINOLOGY (2004)
Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction
XJ Du et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II:: Modulated by G proteins, kinases, and myosin phosphatase
AP Somlyo et al.
PHYSIOLOGICAL REVIEWS (2003)
Diuretic versus α-blocker as first-step antihypertensive therapy -: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
MH Alderman
HYPERTENSION (2003)
The α1A/C- and α1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse
TD O'Connell et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin:: A placebo-controlled study
MA Raskind et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Gene expression profile of neurodegeneration induced by alpha(1B)-adrenergic receptor overactivity: NMDA/GABA(A) dysregulation and apoptosis
J Yun et al.
BRAIN (2003)
The alpha(1B)-adrenergic receptor decreases the inotropic response in the mouse Langendorff heart model
SA Ross et al.
CARDIOVASCULAR RESEARCH (2003)
alpha 1d adrenoceptor signaling is required for stimulus induced locomotor activity
A Sadalge et al.
MOLECULAR PSYCHIATRY (2003)
Knockout of the α1A/C-adrenergic receptor subtype:: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure
DG Rokosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cardiovascular influences of α1b-adrenergic receptor defect in mice
C Vecchione et al.
CIRCULATION (2002)
Cytokines regulate α1-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells
CJ Heijnen et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Distribution of alpha-1 adrenoceptor subtypes in RNA and protein in rabbit eyes
F Suzuki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery
A Christopoulos
NATURE REVIEWS DRUG DISCOVERY (2002)
The alpha(lD)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction
A Tanoue et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Targeted α1A-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy
G Lin et al.
CIRCULATION RESEARCH (2001)
Cardiac-directed overexpression of wild-type α1B-adrenergic receptor induces dilated cardiomyopathy
I Lemire et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
CSF norepinephrine concentrations in posttraumatic stress disorder
TD Geracioti et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the α1B-adrenergic receptor
MJ Zuscik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A behavioral study of alpha-1b adrenergic receptor knockout mice: Increased reaction to novelty and selectively reduced learning capacities
M Spreng et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2001)
Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration:: Multiple system atrophy
MJ Zuscik et al.
NATURE MEDICINE (2000)
Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the α1b-adrenoceptor
J Knauber et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2000)
In situ hybridization and immunocytochemistry of α1-adrenoceptors in human peripheral blood lymphocytes
SK Tayebati et al.
JOURNAL OF AUTONOMIC PHARMACOLOGY (2000)
Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies
M Tanaka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart
AD Eckhart et al.
CIRCULATION RESEARCH (2000)
Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts
BH Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
Share Paper
